← Leaderboards
Tom Cunningham
University Of Cincinnati
$3,936,118
Attributed
$3,936,118
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $869.9K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,936,118 · 2
By mechanism
R35$2,107,741 · 1
R01$1,828,377 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- J. Wesley Pike$17,731,713
- Carolyn M Price$9,966,184
- Jason Aaron Stewart$1,437,093
- Joseph Paul Broderick$95,619,410
- Thomas Doetschman$8,666,600
Others in their field
Other Emerging Leaders on “Normal Tissue Morphology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$24,664,682
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,339,595
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Quy Phung · Leidos Biomedical Research, Inc.$12,889,396
- Leonard Freedmand · Leidos Biomedical Research, Inc.$9,965,931
Research focus
Normal Tissue MorphologyPropertyMetabolismNext GenerationPhenotypeProgramsEconomicsMetabolicMolecularMouse ModelNucleotide MetabolismNucleotidesLoss Of FunctionProductionBiochemicalAffectCellsBiochemistryFoundationsEnzymesFutureGeneticMalignant NeoplasmsRibose-Phosphate Pyrophosphokinase
Grant awards (11)
Defining the biological roles of PRPS isozymes in normal and diseased settings$401,250
R35 · FY2023 · GM · contact PI
Investigating Mechanisms of Deregulated Nucleotide Metabolism in Cancer$359,801
R01 · FY2023 · CA · contact PI
Defining the biological roles of PRPS isozymes in normal and diseased settings$401,250
R35 · FY2022 · GM · contact PI
Investigating Mechanisms of Deregulated Nucleotide Metabolism in Cancer$367,144
R01 · FY2022 · CA · contact PI
Defining the biological roles of PRPS isozymes in normal and diseased settings$401,250
R35 · FY2021 · GM · contact PI
Investigating Mechanisms of Deregulated Nucleotide Metabolism in Cancer$367,144
R01 · FY2021 · CA · contact PI
Defining the biological roles of PRPS isozymes in normal and diseased settings$401,250
R35 · FY2020 · GM · contact PI
Investigating Mechanisms of Deregulated Nucleotide Metabolism in Cancer$367,144
R01 · FY2020 · CA · contact PI
Defining the biological roles of PRPS isozymes in normal and diseased settings$101,491
R35 · FY2020 · GM · contact PI
Defining the biological roles of PRPS isozymes in normal and diseased settings$401,250
R35 · FY2019 · GM · contact PI
Investigating Mechanisms of Deregulated Nucleotide Metabolism in Cancer$367,144
R01 · FY2019 · CA · contact PI